Sigyn Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) - USD ($)	Jun. 30, 2022	Jun. 01, 2022	May 10, 2022	Apr. 28, 2022	Mar. 23, 2022	Dec. 31, 2021	Dec. 31, 2020	Sep. 17, 2020	Jun. 23, 2020	Jun. 22, 2020	Jan. 28, 2020
Short-Term Debt [Line Items]
Convertible notes payable	$ 1,278,316					$ 700,816	$ 616,500
Original issue discount	(64,659)					(53,614)
Debt discount	(268,438)
Total convertible notes payable	945,219					647,202
Convertible Promissory Note One [Member]
Short-Term Debt [Line Items]
Convertible notes payable	457,380					457,380	385,000				$ 457,380
Convertible Promissory Note Two [Member]
Short-Term Debt [Line Items]
Convertible notes payable	60,500					60,500	50,000		$ 60,500
Convertible Promissory Note Three [Member]
Short-Term Debt [Line Items]
Convertible notes payable	182,936					182,936	181,500	$ 199,650
Convertible Promissory Note Four [Member]
Short-Term Debt [Line Items]
Convertible notes payable	220,000				$ 220,000
Convertible Promissory Note Five [Member]
Short-Term Debt [Line Items]
Convertible notes payable	110,000			$ 110,000
Convertible Promissory Note Six [Member]
Short-Term Debt [Line Items]
Convertible notes payable	110,000		$ 110,000
Convertible Promissory Note Seven [Member]
Short-Term Debt [Line Items]
Convertible notes payable	55,000	$ 55,000
Convertible Promissory Note Eight [Member]
Short-Term Debt [Line Items]
Convertible notes payable	$ 82,500									$ 82,500